| |
| |
|
| Insider
Information: |
Cole Douglas G. |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
37,053 |
|
|
Indirect Shares
|
395,565 |
|
|
| Direct
Value |
$713,854 |
|
|
|
Indirect Value
|
$5,933,475 |
|
|
| Total
Shares |
432,618 |
|
|
| Total
Value |
$6,647,329 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Aveo Pharmaceuticals Inc |
AVEO |
Director |
2010-03-17 |
0 |
2011-05-16 |
395,565 |
Premium* |
|
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2016-08-10 |
2,778 |
2014-06-23 |
0 |
Premium* |
|
|
Editas Medicine, Inc. |
EDIT |
Director |
2017-08-17 |
3,171 |
2016-08-11 |
0 |
Premium* |
|
|
Quanterix Corp |
QTRX |
|
2019-01-02 |
4,540 |
2018-08-07 |
0 |
Premium* |
|
|
Denali Therapeutics Inc. |
DNLI |
Director |
2023-06-01 |
26,564 |
2021-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
42 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-03-17 |
4 |
A |
$0.00 |
$0 |
I/I |
869,474 |
869,474 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-03-17 |
4/A |
A |
$0.00 |
$0 |
I/I |
819,915 |
819,915 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2011-03-17 |
4/A |
A |
$0.00 |
$0 |
I/I |
819,915 |
819,915 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2014-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,861 |
1,861 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Director |
– • – |
2016-08-10 |
4 |
A |
$0.00 |
$0 |
D/D |
917 |
2,778 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • – |
2016-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,485 |
1,485 |
0 |
- |
|
| EDIT |
Editas Medicine, Inc. |
Director |
– • – |
2017-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
1,686 |
3,171 |
0 |
- |
|
| QTRX |
Quanterix Corp |
Director |
– • – |
2018-08-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,270 |
2,270 |
0 |
- |
|
| QTRX |
Quanterix Corp |
|
– • – |
2019-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,270 |
4,540 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,074 |
5,327 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2022-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,986 |
22,348 |
0 |
- |
|
| DNLI |
Denali Therapeutics Inc. |
Director |
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
4,216 |
26,564 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-01 |
4 |
AS |
$15.02 |
$163,732 |
I/I |
(10,900) |
859,196 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-02 |
4 |
AS |
$14.50 |
$399,406 |
I/I |
(27,550) |
833,217 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-03 |
4 |
AS |
$14.90 |
$311,451 |
I/I |
(20,898) |
813,511 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-06 |
4 |
AS |
$14.92 |
$216,396 |
I/I |
(14,501) |
799,837 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-07 |
4/A |
AS |
$14.93 |
$93,981 |
I/I |
(6,294) |
744,343 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-07 |
4 |
AS |
$14.93 |
$93,981 |
I/I |
(6,294) |
807,576 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-08 |
4 |
AS |
$14.93 |
$409,093 |
I/I |
(27,400) |
781,738 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-08 |
4/A |
AS |
$14.93 |
$385,772 |
I/I |
(25,838) |
718,505 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-08 |
4/A |
AS |
$14.93 |
$409,093 |
I/I |
(27,400) |
7,185,058 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-09 |
4 |
AS |
$14.39 |
$120,910 |
I/I |
(8,400) |
773,817 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-10 |
4 |
AS |
$14.47 |
$131,699 |
I/I |
(9,100) |
765,236 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-13 |
4 |
AS |
$14.54 |
$154,119 |
I/I |
(10,600) |
755,240 |
0 |
- |
|
| AVEO |
Aveo Pharmaceuticals Inc |
Director |
– • – |
2010-12-14 |
4 |
AS |
$14.06 |
$153,247 |
I/I |
(10,900) |
744,962 |
0 |
- |
|
42 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
